Anson Funds Management’s Cascadian Therapeutics, Inc. CASC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-981,428
| Closed | -$3.65M | – | 67 |
|
|
2017
Q2 | $3.65M | Buy |
981,428
+310,499
| +46% | +$1.15M | 1.15% | 16 |
|
|
2017
Q1 | $2.78M | Buy |
670,929
+441,643
| +193% | +$1.83M | 1.15% | 17 |
|
|
2016
Q4 | $988K | Buy |
229,286
+123,003
| +116% | +$530K | 0.31% | 25 |
|
|
2016
Q3 | $1.05M | Sell |
106,283
-43,384
| -29% | -$427K | 0.22% | 26 |
|
|
2016
Q2 | $847K | Buy |
149,667
+35,500
| +31% | +$201K | 0.16% | 32 |
|
|
2016
Q1 | $870K | Sell |
114,167
-23,700
| -17% | -$181K | 0.13% | 29 |
|
|
2015
Q4 | $1.84M | Buy |
+137,867
| New | +$1.84M | 0.59% | 22 |
|